EARLY MOLECULAR SIGNATURES OF THERAPEUTIC RESPONSE TO VEDOLIZUMAB THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS IDENTIFIED USING A LONGITUDINAL MULTI-OMICS APPROACH

Nathan Baran  1     Neha Mishra  1     Konrad Aden  2     Florian Tran  3     Johanna Ira Blase  1     Claudio Conrad  3     Susanna Nikolaus  4     Stefan Schreiber  5     Philip Rosenstiel  1    
1 Kiel University, University Hospital Schleswig-Holstein, Kiel, Germany
2 IKMB + First Medical Department, Kiel, Germany
3 University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany
4 Univers.-Klinik Schleswig-Holstein, Kiel, Germany
5 University Hospital Schleswig-Holstein, Kiel, Germany

Topic
IBD, Immunology, Nurses

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing